Tradestie Institutional Equity Comparison Engine
MYGN vs QLTI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MYGN Overall Edge
MYGN Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Myriad Genetics Inc (MYGN) driven by superior Valuation, Growth & Margin, Options & Structure while QLTI counters with relative strength in Momentum & Technical. Fundamentally, MYGN trades at 54.0x Forward P/E with -13.3% operating margin (-1.5% YoY revenue) versus QLTI at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MYGN sits in SURGE (22nd %ile IV; Dealer Gamma Walls on Pro) against QLTI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
MYGN
MYGN 54.0x vs QLTI N/M Fwd P/E
Growth & Margin Winner
MYGN
Op Margin -13.3% vs N/A ยท YoY -1.5% vs N/A
Momentum & Technical Winner
QLTI
1Y -12.3% vs +7.0% ยท 52W Pos 53% vs 86%
Options & Structure Winner
MYGN
SURGE (22nd %ile IV) vs UNCLASSIFIED (N/A IV)
MYGN
NASDAQ
Myriad Genetics Inc
In Vitro & In Vivo Diagnostic Substances
$5.57
-1.59% 1D
Market Cap
$542.9M
1M Return
+39.95%
1Y Return
-12.28%
Forward P/E
54.0x
Unified AI Score
46.2 / 100
HOLD
Tech 30.0
Fund 43.0
Flow 56.0
Mom 50.0
QLTI
NYSE Arca
GMO International Quality ETF
Institutional Equity
$28.11
-0.81% 1D
Market Cap
N/A
1M Return
+2.85%
1Y Return
+6.95%
Forward P/E
N/M
Unified AI Score
47.8 / 100
HOLD
Tech 50.0
Fund 35.0
Flow 50.0
Mom 11.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MYGN -12.28%
QLTI +6.95%
Spread: +20.35 pp (QLTI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MYGN TTM Op. Margin: -13.3%
QLTI TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MYGN vs QLTI. Trailing 12-month operating profitability (MYGN -13.3% vs QLTI N/A) and valuation multiples (MYGN 54.0x vs QLTI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MYGN | QLTI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $542.9M | N/A | Larger Scale | MYGN |
| Trailing P/E Ratio Valuation | 54.0x | N/M | Lower Multiple | MYGN |
| Forward P/E Ratio Valuation | 54.0x | N/M | Lower Multiple | MYGN |
| Revenue Growth (YoY) Growth | -1.5% | N/A | Higher Growth | MYGN |
| Operating Margin (TTM) Profitability | -13.3% | N/A | Higher Margin | MYGN |
| Net Profit Margin Profitability | -16.1% | N/A | Higher Margin | MYGN |
| Return on Equity (ROE) Capital Efficiency | -40.2% | N/A | Higher ROE | MYGN |
| 52-Week Range Position Momentum | 53% ($3โ$8) | 86% ($24โ$29) | Stronger Trend | QLTI |
| Beta / 30D Volatility Risk Regime | 0.68ฮฒ ยท 122% Vol | 0.81ฮฒ ยท 16% Vol | Lower Realized Risk | QLTI |
| Unified Institutional Score Composite Signal | 46.2 / 100 (HOLD) | 47.8 / 100 (HOLD) | Higher Composite | QLTI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MYGN vs QLTI Buy Guide
MYGN
SURGE
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
22nd %ile
IV Regime
Compressed (<25th %ile)
QLTI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MYGN nor QLTI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.